Cancer has always been thought of as something that grows rapidly and uncontrollably, but this view may be wrong. New evidence suggests that cancer alternatively uses the "accelerator" and the "brake" in order to survive.
Apr 27, 2018
0
3
The class of drugs currently prescribed to treat male erectile dysfunction has been flagged for its potential to be included in new trials for anti-cancer drugs, in a new clinical study published today in the open access ...
Apr 11, 2018
0
7
On average, 1 in 10 children who enroll in pediatric phase I cancer trials are improved after the trial, and 1 in 50 die from drug-related complications, according to a new systematic review and meta-analysis published this ...
Feb 20, 2018
0
2
A team of researchers at the University of Georgia has developed a non-invasive method of delivering drugs directly to cancerous tissue using magnetic forces, a form of treatment that could significantly reduce the toxic ...
Feb 2, 2018
0
7
A novel approach developed by researchers from the University of Leicester and the MRC Toxicology Unit could help to predict how well patients respond to drugs designed to fight various forms of cancer.
Nov 8, 2017
0
0
Anti-cancer drugs called mTOR inhibitors slow the growth of cancer cells but show limited ability to cause cancer cell death. New studies explain why.
Oct 5, 2017
0
0
Cancer is one of the major causes of death worldwide affecting 8.2 million of people per year, and in the US, the number of new cases will achieve 1.6 million in 2017. The global impact of this disease costs a trillion of ...
Aug 28, 2017
0
105
An article published in Experimental Biology and Medicine (Volume 242, Issue 14, August, 2017) reports that a plant virus-based system can be used to deliver anti-cancer drugs. The study, led by Dr. Nicole Steinmetz in the ...
Aug 18, 2017
0
0
Scientists at The University of Nottingham are tackling a tumour survival mechanism that has left experts baffled for more than 50 years.
Jun 28, 2017
0
2
A method to more accurately test anti-cancer drugs has now been developed at the Sahlgrenska Academy, University of Gothenburg. The method paves the way to much earlier assessment of who benefits from a specific drug and ...
Jun 14, 2017
0
0
